SACRED HEART HOSPITAL
1. Target Overview & Investment Thesis
SACRED HEART HOSPITAL is a 99-bed suburban community hospital in LEHIGH, PA with $48.8M in net patient revenue and a -9.5% operating margin. The hospital serves a payer mix of 10.2% Medicare, 7.4% Medicaid, and 82.4% commercial.
Thesis: Turnaround. Our ML models identify $3.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -9.5% to -2.1% (+736bps).
| Net Revenue HCRIS | $48.8M |
| Current EBITDA COMPUTED | $-4.6M |
| Operating Margin COMPUTED | -9.5% |
| Occupancy HCRIS | 58.2% |
| Revenue / Bed COMPUTED | $493K |
| Net-to-Gross HCRIS | 12.1% |
| Distress Probability ML | 45.4% |
2. Market Context & Competitive Position
PA has 225 Medicare-certified hospitals with a median operating margin of -4.4%. The target's margin of -9.5% places it below the state median. Among 103 size-comparable peers (50-198 beds), the median margin is -4.5%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (50-198), prioritizing same-state peers. 103 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| SACRED HEART HOSPITAL (Target) | PA | 99 | $48.8M | -9.5% |
| ST LUKE HOSPITAL ANDERSON CAMP | PA | 193 | $433.0M | 20.6% |
| THE GETTYSBURG HOSPITAL | PA | 76 | $341.8M | 18.4% |
| ST. JOSEPH MEDICAL CENTER | PA | 132 | $334.8M | 13.2% |
| EPHRATA COMMUNITY HOSPITAL | PA | 115 | $291.8M | 3.8% |
| EINSTEIN MEDICAL CENTER MONTGO | PA | 175 | $276.3M | 6.9% |
| THE GOOD SAMARITAN HOSPITAL | PA | 145 | $269.5M | -5.0% |
| WILKES-BARRE GENERAL HOSPITAL | PA | 188 | $262.1M | -13.0% |
| UPMC ST MARGARET | PA | 185 | $248.5M | -21.3% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.6M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.0M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $976K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $966K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $594K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $31K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-4.6M |
| + RCM Uplift | +$3.6M |
| Pro Forma EBITDA | $-1.0M |
| Current Margin | -9.5% |
| Pro Forma Margin | -2.1% |
| WC Released (1x) | $1.9M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-7.1M | $5.5M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-7.1M | $3.7M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-6.4M | $13.3M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-6.4M | $12.6M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-7.8M | $-10.2M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-7.8M | $-13.7M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 103 hospitals with 50-198 beds
- Same-state prioritization (n=104)
- Comp margins: P25=-19.5% / P50=-4.5% / P75=8.2%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.